Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
Key Details
- 1scSurvival is a machine learning model designed for single-cell resolution analysis in cancer assessment.
- 2Developed with NIH funding by Oregon Health & Science University researchers.
- 3Tested on data from over 150 cancer patients, the tool linked specific tumor and immune cell populations to varying risk and survival outcomes.
- 4The model outperformed traditional methods in predicting outcomes in melanoma and liver cancer.
- 5Research appeared in the journal Cancer Discovery on April 21, 2026.
Why It Matters
Single-cell analytics and AI are at the cutting edge of precision oncology, offering deeper insight into tumor heterogeneity and treatment response. These advances may significantly enhance radiology's role in prognostication and personalized care, especially as multi-modal data integration becomes more common.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
New AI Method Removes Artifacts in Super-Resolution Fluorescence Microscopy
Researchers unveil Adaptive-SN2N, a self-supervised deep learning framework that suppresses background artifacts in super-resolution fluorescence microscopy images.